Mark Plavsic

Chief Tech/Sci/R&D Officer bei AURA BIOSCIENCES, INC.

Vermögen: 2 Mio $ am 31.03.2024

63 Jahre

Health Technology

Consumer Services

Commercial Services

Aktive Positionen von Mark Plavsic

Unternehmen	Position	Beginn	Ende
AURA BIOSCIENCES, INC.	Chief Tech/Sci/R&D Officer	02.10.2023	-
TeraPore Technologies, Inc. TeraPore Technologies, Inc. Chemicals: SpecialtyProcess Industries TeraPore Technologies, Inc. develops cutting-edge membrane technologies for high-permeability, high-resolution nanofiltration. The company was founded by Rachel Dorin in 2013 and is headquartered in	Director/Board Member	-	-

Unternehmen	Position	Beginn	Ende
FATE THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	15.06.2021	06.03.2023
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-	-
Torque Therapeutics, Inc. Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.	Corporate Officer/Principal	-	-
LYSOGENE	Chief Tech/Sci/R&D Officer	-	-

University of Belgrade

Doctorate Degree

International

Operativ

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	2
Doctorate Degree	1

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	3
AURA BIOSCIENCES, INC.	Health Technology
FATE THERAPEUTICS, INC.	Health Technology
LYSOGENE	Commercial Services

Private Unternehmen	3
Genzyme Corp. Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.	Health Technology
Torque Therapeutics, Inc. Torque Therapeutics, Inc. BiotechnologyHealth Technology Torque Therapeutics, Inc. develops immunotherapies to address cancers focused on the specific modulation of immune cell subsets. The company was founded by Bart Henderson, Ulrik B. Nielsen, Darrell J. Irvine, and Thomas Lars Andresen and is headquartered in Cambridge, MA.	Health Technology
TeraPore Technologies, Inc. TeraPore Technologies, Inc. Chemicals: SpecialtyProcess Industries TeraPore Technologies, Inc. develops cutting-edge membrane technologies for high-permeability, high-resolution nanofiltration. The company was founded by Rachel Dorin in 2013 and is headquartered in	Process Industries